Skip to main content

Is farmacovigilanza.eu a Scam? Security Check Results - Zadig srl Società Benefit Reviews

Z

Is farmacovigilanza.eu Safe? Security Analysis for Zadig srl Società Benefit

Check if farmacovigilanza.eu is a scam or legitimate. Free security scan and reviews.

HealthcareItalysmall
Drupal 7jQuery 2.2Google AnalyticsFont Awesome 6EU Cookie Compliance module
Analyzed 10/3/2025Completed 6:38:13 PM
47
Security Score
HIGH RISK

AI Summary

Farmacovigilanza.eu is an Italian pharmacovigilance-focused website operated by Zadig srl Società Benefit, providing independent scientific information, news, case reports, and educational courses related to drug safety. The site targets healthcare professionals and informed citizens interested in pharmacovigilance. Technically, it is built on Drupal 7, uses Google Analytics for tracking, and implements a cookie consent mechanism compliant with GDPR. The hosting is provided by Aruba Business Srl, consistent with the WHOIS data. Security posture is good with HTTPS and standard security headers, though no explicit security or incident response policies are published. Overall, the site is professional, content-rich, and trustworthy with no signs of blocking or adult content.

Detected Technologies

Drupal 7jQuery 2.2Google AnalyticsFont Awesome 6EU Cookie Compliance module

🧠AI Business Intelligence

Technology stack, business insights, and market analysis powered by AI.

Business Intelligence

Market & Strategic Analysis

The website occupies a niche position in the Italian healthcare sector, focusing on pharmacovigilance information dissemination. It leverages partnerships with regulatory agencies and educational platforms to provide value-added services such as FAD ECM courses. The business model appears to be a mix of free content and paid educational offerings. The company behind the site, Zadig srl Società Benefit, is a small-sized entity with a history dating back to at least 2011. The site’s ecosystem includes partner domains that enhance its credibility and reach within the healthcare community.

Security Posture Analysis

Comprehensive Security Assessment

The website demonstrates a mature security posture with enforced HTTPS, presence of key security headers, and privacy-compliant cookie consent. No critical vulnerabilities or exposed sensitive data were detected in the analysis. However, the absence of a publicly available security policy and incident response contact information indicates room for improvement in transparency and readiness. Regular updates to the Drupal CMS and modules are recommended to maintain security. The site respects GDPR requirements and anonymizes IPs in analytics, reflecting good privacy practices.

Strategic Recommendations

Priority Actions for Security Improvement

1

Publish a dedicated security policy and incident response page to improve transparency.

Observations

AI-powered comprehensive website and business analysis.

AI-Enhanced Website Analysis

Business Insights

Company:

Zadig srl Società Benefit

Description:

Farmacovigilanza.eu is a specialized Italian website focused on pharmacovigilance, providing news, case reports, regulatory agency updates, and educational resources related to drug safety and monitoring. It targets healthcare professionals and citizens interested in independent and scientific information about medicines.

Key Services:
Pharmacovigilance news and updatesCase reports on drug safetyEducational courses (FAD ECM)Links to regulatory agencies and scientific resources
Content Quality:

good

Branding:

consistent

Technical Stack

Technologies:
Drupal 7jQuery 2.2Google AnalyticsFont Awesome 6EU Cookie Compliance module
Frameworks:
Drupal
Performance:

moderate

Mobile:

good

Accessibility:

basic

SEO:

good

Security Assessment

Security Score:
80/100
Best Practices:
  • HTTPS enforced
  • IP anonymization in Google Analytics
  • Cookie consent with opt-in mechanism

Analytics & Tracking

Services:
Google AnalyticsGoogle Tag Manager
Tracking Level:moderate
Privacy Compliance:good

Advertising & Marketing

Transparency Level:basic

Website Quality Assessment

Design Quality:good
User Experience:good
Content Relevance:good
Navigation Clarity:good
Professionalism:good
Trustworthiness:high

Key Observations

1

Website is a specialized pharmacovigilance information portal in Italian.

🛡️Security Headers

HTTP security headers analysis and recommendations.

Security Headers

HTTP security headers analysis

40/100
Score

Missing Strict-Transport-Security header

HIGH

Forces HTTPS connections

Missing Content-Security-Policy header

HIGH

Controls resources the browser is allowed to load

Missing X-XSS-Protection header

MEDIUM

Legacy XSS protection (deprecated but still recommended)

Missing Referrer-Policy header

LOW

Controls referrer information sent with requests

Missing Permissions-Policy header

MEDIUM

Controls browser features and APIs

Sensitive data may be cached

LOW

Cache-Control header should include "no-store" for sensitive pages

👤GDPR Compliance

Privacy and data protection assessment under GDPR regulations.

GDPR Compliance

Privacy and data protection assessment

10/100
Score

No Privacy Policy found

HIGH

GDPR requires a clear and accessible privacy policy

No Cookie Policy found

HIGH

GDPR requires clear information about cookie usage

No Cookie Consent Banner found

HIGH

GDPR requires explicit consent for non-essential cookies

EU business without adequate privacy measures

CRITICAL

EU businesses are subject to strict GDPR requirements

Third-party services without privacy policy

HIGH

Detected services: Google Analytics, Facebook

GDPR Compliance Analysis

Privacy Policy0% confidence
Cookie Policy0% confidence
Contact Information Found90% confidence
phone

🛡️NIS2 Compliance

Network & Information Security Directive compliance assessment.

NIS2 Compliance

Network & Information Security Directive

17/100
Score

No information security framework found

HIGH

NIS2 requires documented cybersecurity and information security measures

No vulnerability disclosure policy

MEDIUM

NIS2 encourages coordinated vulnerability disclosure

No security policy documentation found

HIGH

NIS2 requires documented cybersecurity governance and risk management

No incident response procedures found

HIGH

NIS2 requires documented incident response and business continuity plans

No business continuity planning found

MEDIUM

NIS2 emphasizes operational resilience and business continuity

No security contact information

HIGH

NIS2 requires clear incident reporting channels

No vulnerability reporting mechanism

MEDIUM

Clear vulnerability reporting supports coordinated disclosure

No NIS2 reference found

LOW

Consider explicitly mentioning NIS2 compliance efforts

📧Email Security

SPF, DKIM, and DMARC validation and email security assessment.

Email Security

SPF, DKIM, and DMARC validation

75/100
Score

Weak DKIM Key

HIGH

DKIM selector 'default' uses 24-bit key

No BIMI Record

LOW

BIMI displays brand logos in email clients

No MTA-STS Policy

MEDIUM

MTA-STS enforces TLS for email delivery

No TLS-RPT Record

LOW

TLS-RPT provides reporting for email TLS issues

SPF
Sender Policy Framework
DKIM
DomainKeys Identified Mail
DMARC
Domain-based Message Authentication
MX Records
Mail Exchange Records
BIMI
Brand Indicators
MTA-STS
Mail Transfer Agent Security
TLS-RPT
TLS Reporting
DNSSEC
DNS Security
SPF Details
Record:
v=spf1 ip4:80.211.154.110 -all
DNS Lookups:0/10
Policy:-all
DKIM Selectors Found
Selector:default(24-bit rsa)

🏆SSL/TLS Security

Certificate validity and encryption analysis.

SSL/TLS Security

Certificate validity and encryption analysis

62/100
Score

Weak Protocols Supported

HIGH

Server supports weak protocols: TLSv1.1

OCSP Stapling Not Enabled

LOW

OCSP stapling improves performance and privacy

Certificate Transparency Not Implemented

LOW

Certificate is not logged in Certificate Transparency logs

SSL Certificate Expires Within 90 Days

MEDIUM

SSL certificate expires in 61 days

Mixed Content Detected

MEDIUM

12 resources loaded over insecure HTTP

Partial SSL/TLS Assessment

LOW

Completed 3 of 4 security checks due to time constraints

Protocol Support

TLSv1.3TLSv1.2TLSv1.1

OCSP Status

OCSP Stapling Disabled

📊DNS Health

DNS configuration and security assessment.

DNS Health

DNS configuration and security assessment

75/100
Score

DNSSEC Not Enabled

MEDIUM

DNSSEC is not configured for this domain

CAA Records Not Configured

LOW

Certificate Authority Authorization (CAA) records not found

No DMARC Record

MEDIUM

DMARC policy not configured

Domain Registration Details

DNS Records

A Records:80.211.154.110
Name Servers:
ns3.stage-zadig.itDNS only
ns4.stage-zadig.itDNS only
MX Records:
10: mail.zadig.it
SOA:Serial: 1728290285, TTL: 10800s

DNSSEC Status

DNSSEC Not Enabled

DNS Performance

Resolution Time:135ms

SPF Analysis

SPF Record:
v=spf1 ip4:80.211.154.110 -all

Network Security

Port scanning and network exposure analysis.

Network Security

Port scanning and network exposure analysis

20/100
Score

High-Risk Service Exposed: FTP

HIGH

Port 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer

Service Exposed: SSH

MEDIUM

Port 22 (SSH) is publicly accessible - SSH - Secure but can be brute-forced

🔧Technical Analysis

Detailed technical findings and analysis from AI assessment.

Technical Analysis

Comprehensive security assessment findings

Additional Findings

The site is built on Drupal 7, a mature but aging CMS platform, using jQuery 2.2 and Font Awesome 6 for UI elements. Google Analytics and Google Tag Manager are used for user tracking with IP anonymization enabled. The hosting provider is Aruba Business Srl, a reputable Italian hosting company. Performance is moderate, with good mobile optimization and basic accessibility features. SEO is supported by proper meta tags and structured navigation. The site uses an EU Cookie Compliance module with an opt-in consent mechanism, aligning with GDPR requirements. Technical debt may exist due to Drupal 7 usage, suggesting a future upgrade path to newer CMS versions.
Analyze Another Website